Sign in
4

Changes in Ownership

Structure Therapeutics Inc. Filed Acc 0001698149-26-000003

CHIEF EXECUTIVE OFFICER acquired 260,217 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Stevens Raymond C CHIEF EXECUTIVE OFFICER 2026-03-19 Grant or award +260,217 1,401,593 D
Derivatives
Stevens Raymond C CHIEF EXECUTIVE OFFICER 2026-03-19 Grant or award · Employee Stock Option (right to buy) +322,230 322,230 D
Loading xslF345X06/form4-03232026_040301.xml…